MKT Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
LMFP
HCM
AAMU
HPC
CRM
CNB
MKT Advisors's ABBV Position: Q2 2026 in Review
MKT Advisors reduced its AbbVie (ABBV) stake by 20% in Q2 2026, selling an estimated $117K and leaving 2,166 shares worth $552K. The position accounts for 0.17% of the portfolio, ranked #75.
MKT Advisors first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $664K in Q3 2025. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- MKT Advisors held 2,166 shares of AbbVie worth $552K as of Q2 2026.
- MKT Advisors sold 545 AbbVie shares in Q2 2026, an estimated $117K.
- AbbVie made up 0.17% of MKT Advisors's portfolio in Q2 2026, its #75 holding.
- MKT Advisors first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- MKT Advisors's AbbVie position peaked at $664K in Q3 2025.
- 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on MKT Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.